Podcasts about Obesity

Join Dr. Tom Rogers on this week's episode of The Common Sense MD as he tackles one of the most pressing and often misunderstood health issues of our time: obesity. Dr. Rogers explores why obesity is now widely recognized as a disease—and not simply a matter of willpower. Drawing from recent medical research and decades of clinical experience, he breaks down the impact of weight bias, the limitations of traditional diets, and the life-changing potential of revolutionary new medications like GLP-1s and GIPs.Discover why these treatments are being hailed as the greatest medical breakthrough of the 21st century, how they're changing lives, and why addressing the root causes of obesity can transform a patient's overall health. Dr. Rogers also shares candid thoughts on the importance of compassion in medical practice, the social stigma around obesity, and the future of fat acceptance and weight loss therapy.Whether you're a healthcare professional, someone struggling with weight, or simply want to understand more about this major health issue, this episode cuts through the noise with clear, actionable advice. Tune in and learn why treating obesity is about so much more than just the numbers on a scale.This episode is for educational purposes only and does not constitute official medical advice. Please consult with a licensed healthcare provider for personalized care.What did you think of this episode of the podcast? Let us know by leaving a review!Connect with Performance Medicine!Check out our new online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PMedicine⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PerformancemedicineTN⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Performance Medicine

For weight loss, complete avoidance of ultra-processed foods outperforms mere “healthy diet” comprising minimally-processed items; Research fraud undermines anti-dementia drug pipeline; Comprehensive lifestyle modification program scores against cognitive decline; Women's brains especially vulnerable to Omega-3 deficiencies; Bible says “Lame shall walk again” and 21st century science may soon bring about this miracle; Breakthroughs in rheumatoid arthritis treatment.

RFK Jr. issues sharpest ultimatum yet to medical schools: “Start teaching nutrition now or face penalties!” Fast-food outlets continue to abound in teaching hospitals; Once serious causes of flank pain are ruled out, patients are often left to fend for themselves; Potatoes don't increase risk of diabetes—unless you eat French fries; Deep-frying in seed oils can yield harmful byproducts—but so, too, when you substitute with lard; As doctors get more aggressive treating blood pressure, how to minimize medication side effects; New study shows beetroot juice can lower BP by 7 points.

Le cortex cingulaire antérieur : la clé de la volonté et de la motivationPourquoi certaines personnes semblent avancer malgré les obstacles alors que d'autres abandonnent rapidement ? Une partie de la réponse se trouve dans une région fascinante du cerveau : le cortex cingulaire antérieur.Dans cet épisode, on t'explique :✨ Le rôle essentiel de cette zone cérébrale dans la prise de décision, la persévérance et la gestion de l'effort.✨ Comment elle influence notre capacité à rester motivé, même quand c'est difficile.✨ Des pistes concrètes pour mieux comprendre ton propre fonctionnement et nourrir ta volonté au quotidien.Que tu sois en quête de motivation, de discipline ou simplement curieux de comprendre comment ton cerveau t'aide (ou te freine), cet épisode va te donner des clés précieuses pour avancer avec plus de clarté et de force intérieure.

Send us a textKey Opinion Leaders Manal Abdelmalek, Naim Alkhouri, Scott Isaacs and Zobair Younossi join Roger Green to discuss  FDA's approval of semaglutide for patients with non-cirrhotic MASH. This conversation focuses on benefits for patients and ways that having two drugs with different modes of action will change pharmacotherapy choices.This conversation starts with the group describing the sense of "enthusiasm" and "fulfillment" hepatology drug developers feel to see two drugs approved in the US and many other major changes to come (more drug approvals, FDA acceptance of a path to approval that is not based on liver biopsy). One interesting takeaway is that while the approval of semaglutide will likely change the number of patients treated with MASH pharmacotherapy, the greater impact of this approval will be on public awareness of MASH and the accompanying demand for treatment. In terms of actual drug use, the first major change will come among patients living with obesity but not Type 2 diabetes. Most of these patients previously saw their semaglutide prescriptions rejected for payment by health insurers. However, many of these patients will be living with MASH, and they are likely to see their prescriptions approved. Instead, the largest impact may involve increased education and awareness. Scott pointed out that endocrinologists, who frequently prescribe incretin agonists, will have reason to learn how to diagnose and manage MASH in patients they already treat. Zobair noted that an array of companies, starting with pharmaceutical manufacturers and scanning companies, will dramatically increase investments in prescriber and patient education. Another important benefit may come in terms of coverage. Scott points out that most patients living with obesity but not diabetes are unlikely to have their semaglutide prescriptions covered by commercial insurers. Those living with non-cirrhotic MASH are likely to have semaglutide covered. A separate but related point: Naim reports that ~30% of the MASH patients he sees are taking an incretin agonist at the time of initial visit.

Dr. Alex Menze and Dr. Christopher J. Klein discuss whether GLP-1RA usage is linked to radiculoplexus neuropathy and common fibular neuropathy.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213916   

Nutritionist Leyla Muedin discusses the critical role of mitochondrial health throughout the lifespan, citing Dr. Jeffrey Bland's insights on mitochondria as a cornerstone of 21st-century health. The episode explores the benefits of ketosis and the ketogenic diet, particularly in supporting neurological health and conditions like epilepsy, Alzheimer's, and multiple sclerosis. Leyla highlights how ketogenic diets stimulate mitochondrial biogenesis and improve mitochondrial function while addressing potential contraindications for specific populations. The importance of a functional medicine approach and personalized interventions is emphasized for optimal health outcomes.

Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Send us a text! (add your email to get a response)Do you have a family member, friend or roommate whose relationship to food is a little...concerning? Eating disorders hide in plain sight, often disguised as diet culture, fitness goals, or "healthy eating." But beneath these socially acceptable lifestyles lie deadly mental health conditions that claim more lives than almost any other psychiatric disorder.In this episode, we break down the clinical realities of various eating disorders while exploring the profound ways they impact both individuals and their loved ones. We examine anorexia's deadly grip and how it combines food restriction with a distorted body image so powerful that even severely underweight individuals see themselves as fat. The disorder's perfectionism and need for control create a psychological prison that's hard to escape.We discuss bulimia's binge-purge cycle, where out-of-control eating episodes are followed by compensatory behaviors like vomiting or excessive exercise.  We also discuss binge eating disorder and the lesser-known ARFID, which involves food restriction based on sensory issues rather than weight concerns.As you probably already know, these disorders can be incredibly hard on the family dynamic. Eating disorders transform dinner tables into battlegrounds and marriages into war zones. We cover strategies for supporting loved ones without enabling disordered behaviors, emphasizing the importance of family therapy and creating an environment that de-emphasizes weight and appearance.Whether you're worried about someone you love or seeking to understand these complex conditions better, check out KulaMind to get support and community around loving someone with eating disorders. Resources:Hannah, L., Cross, M., Baily, H., Grimwade, K., Clarke, T., & Allan, S. M. (2022). A systematic review of the impact of carer interventions on outcomes for patients with eating disorders. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 27(6), 1953-1962Eating Disorder Hotlines and Crisis ResourcesSupport the showIf you're navigating someone's mental health or emotional issues, join KulaMind, our community and support platform. In KulaMind, we'll help you set healthy boundaries, advocate for yourself, and support your loved one. Follow @kulamind on Instagram for podcast updates and science-backed insights on staying sane while loving someone emotionally explosive. For more info about this podcast, check out: www.alittlehelpforourfriends.com

Metformin for Treatment of Knee Osteoarthritis in Patients With Overweight or ObesityOnce-Weekly Semaglutide in Persons with Obesity and Knee OsteoarthritisSemaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

This week on Health Matters, we bust myths about seed oils and learn the difference between saturated fats and unsaturated fats. Dr. David Majure, a cardiologist at NewYork-Presbyterian and Weill Cornell Medicine, explains different types of fat and fatty acids, such as Omega-3 and Omega-6, including where they come from and what they mean for our health. He also shares the results of several studies that help get to the bottom of the benefits and risks of seed oils.___Dr. David Majure is the medical director of the Heart Transplant Service at NewYork-Presbyterian/Weill Cornell Medical Center and assistant professor of medicine at Weill Cornell Medicine. He specializes in the care of patients with heart failure, patients requiring or who have a heart transplant or ventricular assist device (LVAD), and patients with pulmonary hypertension. Dr. Majure received his medical degree from The Johns Hopkins School of Medicine as well as a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He completed his training in cardiology and advanced heart failure at the University of California, San Francisco, where he also served as an assistant clinical professor of medicine. He subsequently served as director of Research of the Advanced Heart Failure Program at the MedStar Washington Hospital Center in Washington, D.C and Director of Mechanical Circulatory Support at North Shore University Hospital, where he developed the left ventricular assist device (LVAD) program. He has contributed extensively to research and has served as principal investigator in multiple clinical trials, exploring all aspects of advanced heart failure. Dr. Majure has been recognized as a Castle Connolly Top Doctor since 2020.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

Eli Lilly posted data Tuesday from a second Phase III trial of its oral weight loss therapy orforglipron, providing the company with all it needs to head to the FDA with a new drug application. For more in-depth discussion on the oral weight-loss space, check out a special episode of The Weekly. And stay tuned to BioSpace for more unique coverage of this market as we learn which investigational assets will make it across the regulatory finish line and which will join the weight-loss wasteland. On the business side of biopharma, AbbVie turned back to neuropsychiatric therapies this week, acquiring partner Gilgamesh Pharmaceuticals' lead depression candidate for $1.2 billion. The deal is a display of resilience for AbbVie in the neuropsychiatric space as well, after the stunning failure last November of schizophrenia asset emraclidine—picked up in its nearly $9 billion acquisition of Cerevel Therapeutics. And is the cooler late summer weather thawing the IPO market? Neuropsych-focused LB Pharma revealed in an SEC filing on Friday that it plans to take the plunge, ending a six-month stalemate in biotech IPOs.  Finally, the Department of Health and Human Services (HHS) has been busy this past week. On Monday, the CDC named Retsef Levi—a known vaccine critic—to head the agency's COVID-19 immunization working group, just as reports surfaced that the Trump administration could be “within months” of banning the COVID-19 vaccine in the U.S. Meanwhile, the FDA issued new draft guidance for cancer drug developers that prioritizes the use of survival data, and the agency began publishing drug-related adverse event reports daily.   HHS itself has also been the subject of recent headlines, announcing that it will no longer recognize employee unions, and last week, hundreds of HHS staffers penned an open letter calling on Secretary Kennedy to tone down what they called “dangerous and deceitful statements” that have fostered distrust against federal health workers, exposing them to physical harm. This followed the Aug. 8 shooting at CDC headquarters in Atlanta.   Finally, multinational pharmaceutical companies spent more than $48 billion on partnerships with China in the first half of 2025 alone, according to a new report from IQVIA—more than in all of 2024.  

It's nearly impossible to turn on the television or open a magazine without seeing advertisements for the latest weight loss trend: GLP-1 medications, commonly known as Ozempic, Mounjaro, Wegovy, and Zepbound. Approximately 15 million people are estimated to have tried these drugs for weight loss. However, as with any emerging health trend, it's important to consider whether these medications are safe and cost-effective.What are the risks and benefits of these drugs? Is the pharmaceutical industry providing a quick fix for the approximately 42% (or 100 million) U.S. citizens who are obese? Are these medications the only solution to the obesity epidemic, or are lifestyle and dietary changes essential for long-term success? Dr. Nicole Dorotik joins us in this episode to address these questions and more as we explore the latest trends in the pursuit of health and wellness.Special Guest: Dr. Nicole Dorotik Dr. Nicole Dorotik earned her medical degree from the University of Arizona College of Medicine and completed her residency at Long Beach Memorial Hospital in Long Beach, California. She is board-certified in Family Medicine and has over 20 years of clinical experience. Along with her professional accomplishments, Nicole is the proud mom to three great kiddos. Show notes:Weight Comes Back When You Stop Taking Drugs Like Ozempic, Study Finds.https://www.sciencealert.com/weight-comes-back-when-you-stop-taking-drugs-like-ozempic-study-finds#A new era of weight loss: Mental health effects of GLP-1 drugs.https://www.apa.org/monitor/2025/07-08/weight-loss-drugs-mental-healthRx History: The Rise of GLP-1s.https://www.innovativerxstrategies.com/rx-history-glp1s/Unintended consequences: Weight loss drugs are changing the way consumers buy groceries.https://www.post-gazette.com/business/healthcare-business/2025/08/17/glp1-ozempic-grocery-store-food-price-weightloss/stories/202508070069.

In this special episode on Strategies for Staying Full and Satisfied, our host, Dr. Neil Skolnik will moderate a discussion with Lily Correa, registered dietitian about communicating strategies for staying full and satisfied. This special edition of Diabetes Core Update is sponsored by Avocados - Love One Today ®.    For more information, as well as diabetes-friendly mean plans and a free downloadable toolkit just go to:http://loveonetoday.com/SatisfiedEating Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Lilian (Lily) M. Correa, Lily Correa is a registered dietitian and diplomate of the American College of Lifestyle Medicine   Resources and References:   Henning, Susanne M. et al. Hass Avocado Inclusion in a Weight-Loss Diet Supported Weight Loss and Altered Gut Microbiota: A 12-Week Randomized, Parallel-Controlled Trial. Current Developments in Nutrition 2019, Volume 3, Issue 8, ISSN 2475-2991. https://doi.org/10.1093/cdn/nzz068.   Khan, Naiman A. et al. Avocado Consumption, Abdominal Adiposity, and Oral Glucose Tolerance Among Persons with Overweight and Obesity. The Journal of Nutrition 2021, Volume 151, Issue 9p2513-2521. https://doi.org/10.1093/jn/nxab187.   Lichtenstein, Alice H. et al. Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial. Journal of the American Heart Association 2022, Volume 11, Number 14. https://doi.org/10.1161/JAHA.122.02565.   Pacheco, Lorena S. et al. Effects of Different Allotments of Avocados on the Nutritional Status of Families: A Cluster Randomized Controlled Trial. Nutrients 2021, 13(11), 4021. https://doi.org/10.3390/nu13114021.   Senn, MacKenzie K. et al. Associations between avocado intake and measures of glucose and insulin homeostasis in Hispanic individuals with and without type 2 diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Nutrition, Metabolism and Cardiovascular Diseases 2023, Volume 33, Issue 12, 2428 – 2439. https://doi.org/10.1016/j.numecd.2023.08.002.   Wood, Alexis C. et al. Associations between Metabolomic Biomarkers of Avocado Intake and Glycemia in the Multi-Ethnic Study of Atherosclerosis. The Journal of Nutrition 2023, Volume 153, Issue 10, 2797 – 2807. https://doi.org/10.1016/j.tjnut.2023.07.013.   For more resources, research and recipes visit LoveOneToday.com/healthprofessionals.

Send us a textWelcome back to Ending Physician Overwhelm! As we head into the last week of August 2025 and prepare for back-to-school season, it's time to think about something we do constantly as physicians: learning.The Evolution of Medical LearningYou've been a professional learner your entire career. Medical school, residency, fellowship, boards, CME requirements - you've mastered the art of absorbing information and passing tests. But here's the question that might change everything: Who are you actually learning from?If you're like most of us who trained in the early 2000s, your medical education came primarily from older white men reading the same traditional journals and following conventional pathways. While this wasn't inherently wrong, it created a narrow lens that may no longer serve you - or your patients.Breaking Out of Traditional Learning BoxesAs medicine evolves, so should your sources of knowledge. Whether you're exploring:Obesity medicine (where traditional training left massive gaps)Menopause care (practically non-existent in most curricula thanks to the WHI study fallout)Lifestyle medicine approachesNew practice models that prioritize patient connectionYou need voices that reflect the reality of modern healthcare delivery, not just academic theory.The Current Medical Learning LandscapeHere's what's happening right now that affects how you learn:Traditional resources are under threat: With political forces dismantling institutions like ACIP and creating uncertainty around CDC guidance, you're losing historically reliable sources of information.AI is changing everything: Your residents and students are using AI tools that you may not fully understand, yet you're expected to guide them safely through this new landscape.Diversity of voices matters: The patients you serve come from all backgrounds - shouldn't your teachers reflect that diversity too?Finding Your New Learning PathAsk yourself these critical questions:Who is doing the work the way you want to do it?Are you open to being challenged and learning new approaches?Can you unlearn outdated information that's no longer serving your patients?How will you vet new sources of information in an era of compromised traditional resources?Practical Steps for Better LearningSeek out practitioners who:Are actively treating patients (not just publishing papers)Offer practical, real-world applicationsDiscuss the full picture including costs, side effects, and patient experienceChallenge traditional approaches with evidence-based alternativesConsider learning formats beyond traditional CME:Podcasts from practicing physiciansCourses from specialists doing the workMentorship from independent practitionersBooks and resources from diverse voices in medicineThe Power Support the showTo learn more about my coaching practice and group offerings, head over to www.healthierforgood.com. I help Physicians and Allied Health Professional women to let go of toxic perfectionist and people-pleasing habits that leave them frustrated and exhausted. If you are ready to learn skills that help you set boundaries and prioritize yourself, without becoming a cynical a-hole, come work with me.Want to contact me directly?Email: megan@healthierforgood.comFollow me on Instagram!@MeganMeloMD

Wade is the VP of Brand Management and Business Development at Vdriven Consulting. He has had a decorated career in the grocery industry, including stops at Buehler's, Rouses, Jimbo's, and The Fresh Market. WHAT WE GO OVER:Wade's storyA buyer's perspectiveVasa's POV on streamlining review schedules OBJECTIVELYIntegrating loyalty members into category management Innovation setsCONNECT WITH US:Connect with Vasa on LinkedInConnect with Wade on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeGet in touch with Vdriven ConsultingSPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands grow. Check out Growthbuster's newsletter, CPGSPN here. 

In this episode of American Glutton, Ethan Suplee sits down with Dave Knapp, patient advocate and founder of the first patient-centric obesity medicine news platform. Dave shares his deeply personal journey with obesity and type 2 diabetes—from years of yo-yo dieting and keto struggles to discovering GLP-1 medications that changed his life.Together, Ethan and Dave explore misconceptions about obesity, the emotional toll of weight loss, the rise of new medical treatments, and the importance of community in navigating these challenges. This honest, eye-opening conversation is filled with hard truths, hope, and inspiration for anyone on a health journey.SHOW HIGHLIGHTS 00:02 – Welcome and introductions 01:18 – Living with diabetes and obesity 04:40 – Obesity as a chronic disease 08:29 – Misconceptions about type 2 diabetes 10:22 – High school struggles and keto beginnings 13:36 – Diagnosis and the wake-up call 15:51 – Year of keto and frustration 23:24 – Facing surgery and discovering new drugs 26:35 – Building a patient-driven platform 33:46 – Safety concerns and misconceptions 41:46 – Why people resist obesity medications 46:32 – Transfer addiction and mental health 52:06 – Long-term effects and unanswered questions 56:27 – Loose skin and hidden struggles of weight loss 01:00:39 – The misconceptions about rapid results 01:02:55 – Final reflections and gratitude Hosted on Acast. See acast.com/privacy for more information.

Did you know that nearly one in three people with obesity may have fatty liver disease without even knowing it? In this episode, I talk about groundbreaking news in obesity and liver health, focusing on the FDA's recent approval of WeGovy to treat metabolic dysfunction associated steatohepatitis (MASH) with moderate to advanced fibrosis. I share a personal story about a friend who once struggled with fatigue, abnormal liver tests, and fatty liver disease, highlighting how limited treatment options used to be. I explain what MASH is, why it's so serious, and how common it is, especially among people with obesity and metabolic syndrome.  Furthermore, I dive into the ESSENCE trial, which showed that WeGovy not only improved liver inflammation and scarring but in some cases even reversed the disease, all while emphasizing that it works best when combined with lifestyle changes like healthy eating and regular activity.  Don't miss this episode where I break down the latest breakthrough in liver and weight loss care that could change your health journey!   Episode Highlights: FDA approval of WeGovy for treating MASH with fibrosis The ESSENCE trial results showing improvements in liver health Understanding what MASH is and why it's so common Importance of combining medication with lifestyle changes Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

The Food and Drug Administration or FDA regulates roughly 78% of the US food supply. This includes packaged products, food additives, infant formula, ultra-processed foods, and lots more. However, an analysis by the Environmental Working Group found that 99% of new food ingredients enter our food supply through a legal loophole that skirts FDA oversight and seems, to me at least, to be incredibly risky. Today we're speaking with two authors of a recent legal and policy analysis published in the Journal Health Affairs. They explain what this loophole is and its risks and suggest a new user fee program to both strengthen the FDA's ability to regulate food ingredients and address growing concerns about food safety. Our guests are Jennifer Pomeranz Associate Professor of Public Health Policy and Management at New York University School of Global Public Health and Emily Broad, director of Harvard Law School Center for Health Law and Policy Innovation. Interview Summary So Jennifer, let's start with you, help our listeners understand the current situation with food ingredient oversight. And what is this legal loophole that allows food companies to add new ingredients without safety reviews. Sure. So, Congress passed the Food Additives Amendment in 1958, and the idea was to divide food additives and generally recognized as safe ingredients into two different categories. That's where the GRAS term comes from generally recognized as safe? ‘Generally Recognized As Safe' is GRAS. But it circularly defines food additives as something that's not GRAS. So, there's not actually a definition of these two different types of substances. But the idea was that the food industry would be required to submit a pre-market, that means before it puts the ingredient into the marketplace, a pre-market petition to the FDA to review the safety. And then the FDA promulgates a regulation for safe use of a food additive. GRAS ingredients on the other hand, initially thought of as salt, pepper, vinegar, are things like that would just be allowed to enter the food supply without that pre-market petition. The problem is the food industry is the entity that decides which category to place each ingredient. There's no FDA guidance on which category they're supposed to ascribe to these ingredients. What has happened is that the food industry has now entered into the food supply an enormous amount of ingredients under what we call the GRAS loophole, which is allowing it to just bring it to the market without any FDA oversight or even knowledge of the ingredient. So, in essence, what we're having now is that the food industry polices itself on whether to submit this pre-market petition for a food additive or just include it in its products without any FDA knowledge. When you said ‘enormous number of such things,' are we talking dozens, hundreds, thousands? Nobody knows, but the environmental working group did find that 99% of new ingredients are added through this loophole. And that's the concerning part. Well, you can look at some ultra-processed foods and they can have 30 or 40 ingredients on them. That's just one food. You can imagine that at across the food supply, how many things there are. And there are these chemicals that nobody can pronounce. You don't know what's going on, what they are, what they're all about. So, what you're saying is that the food industry decides to put these things in foods. There's some processing reason for putting them in. It's important that the public be protected against harmful ingredients. But the food industry decides what's okay to put in and what's not. Are they required to do any testing? Are there criteria for that kind of testing? Is there any sense that letting the industry police itself amounts to anything that protects the public good? Well, the criteria are supposed to be the same for GRAS or food additives. They're supposed to be meeting certain scientific criteria. But the problem with this is that for GRAS ingredients, they don't have to use published data and they can hold that scientific data to themselves. And you mentioned food labels, the ingredient list, right? That doesn't necessarily capture these ingredients. They use generic terms, corn oil, color additive, food additive whatever. And so, the actual ingredient itself is not necessarily listed on the ingredient list. There is no way to identify them and it's unknown whether they're actually doing the studies. They can engage in these, what are called GRAS panels, which are supposed to be experts that evaluate the science. But the problem is other studies have found that 100% of the people on these GRAS panels have financial conflicts of interest. Okay, so let me see if I have this right. I'm a food company. I develop a new additive to provide color or flavor or fragrance, or it's an emulsifier or something like that. I develop a chemical concoction that hasn't really been tested for human safety. I declare it safe. And the criteria I use for declaring it set safe is putting together a panel of people that I pay, who then in a hundred percent of cases say things are. That's how it works? I can't say that in a hundred percent of cases they say it's safe, but a hundred percent of the people have financial conflicts of interest. That's one of the major concerns there. Well, one can't imagine they would continue to be paid... Exactly. This sounds like a pretty shaky system to be sure. Emily: I wanted to add a couple other really quick things on the last discussion. You were saying, Kelly, like they're using a panel of experts, which indeed are paid by them. That would be best case in some cases. They're just having their own staff say, we think this is generally recognized as safe. And I think there's some examples we can give where there isn't even evidence that they went to even any outside people, even within industry. I think that the takeaway from all of that is that there's really the ability for companies to call all the shots. Make all the rules. Not tell FDA what they're doing. And then as we talked about, not even have anything on the label because it's not a required ingredient if it's, used as part of a processing agent that's not a substance on there. So I was feeling pretty bad when Jennifer is talking about these panels and the heavy conflict... Even worse. Of interest, now I feel worse because that's the best case. Totally. And one other thing too is just you kind of warmed this up by talking about this loophole. When we put an earlier article out that we wrote that was about just this generally recognized as safe, the feedback we got from FDA was this isn't a loophole. Why are you calling this a loophole? And it's pretty clear that it's a loophole, you know? It's big enough to drive thousands of ingredients through. Yes, totally. Emily, you've written about things like partially hydrogenated vegetable oils, trans fats, and red dye number three in particular. Both of which FDA has now prohibited in food. Can you walk us through those cases? You asked about partially hydrogenated oils or trans-fat, and then red dye three, which are two examples that we talk about a little bit in our piece. Actually, one of those, the partially hydrogenated oils was allowed in food through the generally recognized as safe definition. And the other was not. But they are both really good examples of another real issue that FDA has, which is that not only are they not doing a good job of policing substances going into food on the front end, but they do an even worse job of getting things out of food on the backend, post-market once they know that those substances are really raising red flags. And you raised two of the prime examples we've been talking about. With partially hydrogenated oils these are now banned in foods, but it took an extremely long time. Like the first evidence of harm was in the mid-nineties. By 2005, the Institute of Medicine, which is now the National Academies, said that intake of trans fat, of partially hydrogenated oils, should be as low as possible. And there was data from right around that time that found that 72,000 to 228,000 heart attacks in the US each year were caused by these partially hydrogenated oils. And on FDA's end, they started in early 2000s to require labeling. But it wasn't until 2015 that they passed a final rule saying that these substances were not generally recognized as safe. And then they kept delaying implementation until 2023. It was basically more than 20 years from when there was really clear evidence of harm including from respected national agencies to when FDA actually fully removed them from food. And red dye number three is another good example where there were studies from the 1980s that raised concerns about this red dye. And it was banned from cosmetics in 1990. But they still allowed it to be added to food. And didn't ban it from food until early this year. So early 2025. In large part because one of the other things happening is states are now taking action on some of these substances where they feel like we really need to protect consumers in our states. And FDA has been doing a really poor job. California banned red dye about 18 months before that and really spurred FDA to action. So that 20-year delay with between 72,000 and 228,000 heart attack deaths attributable to the trans fats is the cost of delay and inaction and I don't know, conflicts of interest, and all kinds of other stuff that happened in FDA. So we're not talking about something trivial by any means. These are life and death things are occurring. Yes. Give us another example, if you would, about something that entered the food supply and caused harm but made it through that GRAS loophole. The example that I've talked about both in some of the work we've done together and also in a perspective piece in the New England Journal of Medicine that really focused on why this is an issue. There was this substance added to food called tara flour. It came on the scene in 2022. It was in food prepared by Daily Harvest as like a protein alternative. And they were using it from a manufacturer in South America who said we have deemed this generally recognized as safe. Everything about that is completely legal. They deemed it generally recognized as safe. A company put it into food, and they sold that. Up until that point, that's all legal. What happened was very quickly people started getting really sick from this. And so there were, I think, about 400 people across 39 states got sick. Nearly 200 people ended up in the hospital, some of them with liver failure because of this toxicity of tara flour. And so FDA followed the thread they did help work with the company to do a voluntary recall, but it then took them two years, until May, 2024, to declare tara flour not generally recognized as safe. So I think, in some ways, this is a great example because it shows how it's so immediate, the impact of this substance that, again, was legally added to food with no oversight. In some ways it's a misleading example because I think so many of the substances in food, it's not going to be so clear and so immediate. It's going to be year over year, decade over decade as part of a full diet that these are causing cardiovascular risk, thyroid disease, cancer risk, those kinds of things. I'd love to hear from either of you about this. Why is FDA falling down on the job so badly? Is it that they don't have the money to do the necessary testing? Do they not have the authority? Is there not the political will to do this? Is there complete caving into the food industry? Just let them do what they want and we're going let it go? Jennifer: All of the above? Everything you just said? It's all of the above. Emily: Jen, do you wanna talk about the money side? Because that sort of gets to the genesis of the article we worked on, which was like maybe there's a creative solution to that piece. Yes, I'd love to hear about that because I thought that was a very creative thing that you guys wrote about in your paper. That there would be an industry user fee to help produce this oversight. Tell us what you had in mind with that. And then then convince me that FDA would appropriately use this oversight and do its job. So, the idea in the paper was proposing a comprehensive user fee program for the food branch of the FDA. The FDA currently collects user fees for all of human drugs, animal drugs, medical devices, etc. With Tobacco, it's a hundred percent funded by user fees. But food, it only gets 1% of its funding through user fees. And it's important to note user fees fund processes. They don't fund outcomes. It's not like a bribe. And the idea behind user fees and why industry sometimes supports them is actually to bring predictability to the regulatory state. It brings efficiency to reviews. And then this all allows the industry to anticipate timelines so they can bring products to market and know when they're going be able to do it. In the food context, for example, the FDA is required to respond to those food additives petitions that we talked about within 180 days. But they can't respond in time. And they have a lot of timelines that are required of them in the food context that they can't meet. They can't meet their timelines because they're so underfunded. So, we proposed a comprehensive user fee. But one of the main reasons that we think a user fee is important is to address the pre-market issues that I talked about and the post-market issues that Emily talked about. In order to close that GRAS loophole, first of all, FDA needs to either reevaluate its authorities or Congress needs to change its authorities. But it would need resources to be able to do something pre-market. Some of the ideas we had was that the user fee would fund some type of either pre-market review, pre-market notification, or even just a pre-market system where the FDA determines whether a proposed ingredient should go through the GRAS avenue, or through food additive petition. So at least that there will be some type of pre-market oversight over all the ingredients in the food supply. And then also the FDA is so severely lacking in any type of comprehensive post-market into play, they would have the resources to engage in a more comprehensive post-market review for all the ingredients. Could you see a time, and I bring this up because of lawsuits against the food industry for some of these additives that are going on now. The state attorney's generals are starting to get involved, and as you said, Emily, the some states are taking legislative action to ban certain things in the food supply. Do you think there could come a time when the industry will come to government pleading to have a user fee like this? To provide some standardization across jurisdictions, let's say? So, there's two things. The first is Congress has to pass the user fee, and historically, actually, industry has done exactly what you said. They have gone to Congress and said, you know what? We want user fees because we want a streamlined system, and we want to be able to know when we're bringing products to market. The problem in the context of food for the issues we're talking about is that right now they can use the GRAS loophole. So, they have very little incentive to ask for user fees if they can bring all their ingredients into the market through the GRAS loophole. There are other areas where a user fee is very relevant, such as the infant formula 90 day pre-market notification, or for different claims like health claims. They might want user fees to speed those things up, but in terms of the ingredients, unless we close the GRAS loophole, they'd have little incentive to actually come to the table. But wouldn't legal liability change that? Let's say that some of these lawsuits are successful and they start having to pay large settlements or have the State Attorneys General, for example, come down on them for these kinds of things. If they're legally liable for harm, they're causing, they need cover. And wouldn't this be worth the user fee to provide them cover for what they put in the food supply? Yes, it's great to have the flexibility to have all these things get through the loophole, but it'd be great as well to have some cover so you wouldn't have so much legal exposure. But you guys are the lawyers, so I'm not sure it makes sense. I think you're right that there are forces combining out in the world that are pushing for change here. And I think it's hard to disentangle how much is it that industry's pushing for user fees versus right now I think more willing to consider federal regulatory changes by either FDA or by Congress. At the state level this is huge. There's now becoming a patchwork across states, and I think that is really difficult for industry. We were tracking this year 93 bills in 35 states that either banned an additive in the general public, banned it in schools. Banned ultra-processed foods, which most of the states, interestingly, have all defined differently. But where they have had a definition, it's been tied to various different combinations of additives. So that's going on. And then I think you're right, that the legal cases moving along will push industry to really want clear and better standards. I think there's a good question right now around like how successful will some of these efforts be? But  what we are seeing is real movement, both in FDA and in Congress, in taking action on this. So interestingly, the Health Affairs piece that we worked on was out this spring. But we had this other piece that came out last fall and felt like we were screaming into the void about this is a problem generally recognized as safe as a really big issue. And suddenly that has really changed. And so, you know, in March FDA said they were directed by RFK (Robert F. Kennedy), by HHS (Health and Human Services) to really look into changing their rule on generally recognized as safe. So, I know that's underway. And then in Congress, multiple bills have been introduced. And I know there are several in the works that would address additives and specifically, generally recognized as safe. There's this one piece going on, which is there's forces coalescing around some better method of regulation. I think the question's really going to also be like, will Congress give adequate resources? Because there is also another scenario that I'm worried about that even if FDA said we're going now require at least notification for every substance that's generally recognized as safe. It's a flood of substances. And they just, without more resources, without more staff devoted to this, there's no way that they're going to be able to wade through that. So, I think that either the resources need to come from user fees, or at least partially from user fees, from more appropriations and I think, In my opinion, they are able to do that on their own. Even given where current administrative law stands. Because I think it's very clear that the gist of the statute is that FDA should be overseeing additives. And I think a court would say this is allowing everything to instead go through this alternative pathway. But I really think FDA's going to need resources to manage this. And perhaps more of a push from Congress to make sure that they really do it to the best of their ability. I was going to say there's also an alternative world where we don't end up spending any of these resources, and they require the industry just to disclose all the ingredients they've added to food and put it on a database. This is like low hanging fruit, not very expensive, doesn't require funding. And then the NGOs, I hope, would go to work and say, look at this. There is no safety data for these ingredients. You know, because right now we just can't rely on FDA to do anything unless they get more funding to do something. So, if FDA doesn't get funding, then maybe this database where houses every ingredient that's in the food supply as a requirement could be a low resource solution. Jennifer, I'll come back to you in a minute because I'd like to ask how worried should we be about all this stuff that's going into food. But Emily, let me ask you first, does FDA have the authority to do what it needs to do? Let's say all of a sudden that your wish was granted and there were user fees would it then be able to do what needs to be done? I think certainly to be able to charge these user fees in almost all areas, it right now doesn't have that authority, and Congress would need to act. There's one small area which is within the Food Safety Modernization Act for certain types of like repeat inspections or recalls or there's a couple other. FDA isn't charging fees right now because they haven't taken this one step that they need to take. But they do have the authority if they just take those steps. But for everything else, Congress has to act. I think the real question to me is because we now know so many of these substances are going through this GRAS pathway, the question is really can they do everything they need to do on their own to close that loophole? And again, my opinion is Congress could make it clear and if Congress were to act, it would be better. Like they could redefine it in a way that was much more clear that we are drawing a real line. And most things actually should be on the additive side of the line rather than the generally recognized as safe side of the line. But even with their current authority, with the current definition, I think FDA could at least require notification because they're still drawing a line between what's required for additives, which is a very lengthy pre-market process with, you know, a notice and comment procedure and all of these things. My take is FDA do what you can do now. Let's get the show on the road. Let's take steps here to close up the loophole. And then Congress takes time. But they definitely can even strengthen this and give a little more, I think, directives to FDA as to how to make sure that this loophole doesn't recur down the line. In talks that I've given recently, I've shown an ingredient list from a food that people will recognize. And I ask people to try to guess what that food is from its ingredient list. This particular food has 35 ingredients. You know, a bunch of them that are very hard to pronounce. Very few people would even have any idea at all what those ingredients do. There's no sense at all about how ingredient number 17 would interact with ingredient 31, etc. And it just seems like it's complete chaos. And I don't want to take you guys outside your comfort zone because your backgrounds are law. But Jennifer, let me ask you this. You have a background in public health as well. There are all kinds of reasons to be worried about this, aren't there? There are the concerns about the safety of these things, but then there's a concern about what these ultra-processed ingredients do to your metabolism, your ability to control your weight, to regulate your hunger and things like that. It sounds this is a really important thing. And it's affecting almost everybody in the country. The percentage of calories that are now coming from ultra-processed foods is over 50% in both children and adults. So it sounds like there's really reason to worry. Would you agree? Yes. And also, the FDA is supposed to be overseeing the cumulative effects of the ingredients and it doesn't actually enforce that regulation. Its own regulation that it's supposed to evaluate the cumulative effects. It doesn't actually enforce this. So by cumulative effects do you mean the chronic effects of long term use? And, having these ingredients across multiple products within one person's consumption. Also, the FDA doesn't look at things like the effect on the gut microbiome, neurotoxicity, even cancer risk, even though they're supposed to, they say that if something is GRAS, they don't need to look at it because cancer risk is relegated only to food additives. So here we're at a real issue, right? Because if everything's entering through the GRAS loophole, then they're not looking at carcinogen effects. So, I think there is a big risk and as Emily had said earlier, that these are sometimes long-term risks versus that acute example of tara flour that we don't know. And we do know from the science, both older and emerging science, that ultra-processed food has definite impact on not only consumption, increased consumption, but also on diet related diseases and other health effects. And by definition what we're talking about here are ultra-processed foods. These ingredients are only found in ultra-processed foods. So, we do know that there is cause for concern. It's interesting that you mentioned the microbiome because we've recorded a cluster of podcasts on the microbiome and another cluster of podcasts on artificial sweeteners. Those two universes overlap a good bit because the impact of the artificial sweeteners on some of them, at least on the microbiome, is really pretty negative. And that's just one thing that goes into these foods. It really is pretty important. By the way, that food with 35 ingredients that I mentioned is a strawberry poptart. Jennifer: I know that answer! Emily: How do you know that? Jennifer: Because I've seen Kelly give a million talks. Yes, she has. Emily: I was wondering, I was like, are we never going to find out? So the suspense is lifted. Let me end with this. This has been highly instructive, and I really appreciate you both weighing in on this. So let me ask each of you, is there reason to be optimistic that things could improve. Emily, I'll start with you. So, I've been giving this talk the past few months that's called basically like Chronic Disease, Food Additives and MAHA, like What Could Go Right and What Could Go Wrong. And so, I'm going give you a very lawyerly answer, which is, I feel optimistic because there's attention on the issue. I think states are taking action and there's more attention to this across the political spectrum, which both means things are happening and means that the narrative changing, like people are getting more aware and calling for change in a way that we weren't seeing. On the flip side, I think there's a lot that could go wrong. You know, I think some of the state bills are great and some of them are maybe not so great. And then I think this administration, you have an HHS and FDA saying, they're going to take action on this in the midst of an administration that's otherwise very deregulatory. In particular, they're not supposed to put out new regulations if they can get rid of 10 existing ones. There are some things you can do through guidance and signaling, but I don't think you can really fix these issues without like real durable legislative change. So, I'm sorry to be one of the lawyers here. I think the signals are going in the right direction, but jury is out a little bit on how well we'll actually do. And I hope we can do well given the momentum. What do you think, Jennifer? I agree that the national attention is very promising to these issues. The states are passing laws that are shocking to me. That Texas passing a warning label law, I would never have thought in the history of the world, that Texas would be the one to pass a warning label law. They're doing great things and I actually have hope that something can come of this. But I am concerned at the federal level of the focus on deregulation may make it impossible. User fees is an example of where they won't have to regulate, but they could provide funding to the FDA to actually act in areas that it has the authority to act. That is one solution that could actually work under this administration if they were amenable to it. But I also think in some ways the states could save us. I worry, you know, Emily brought up the patchwork, which is the key term the industry uses to try to get preemption. I do worry about federal preemption of state actions. But the states right now are the ones saving us. California is the first to save the whole nation. The food industry isn't going to create new food supply for California and then the rest of the country. And then it's the same with other states. So, the states might be the ones that actually can make some real meaningful changes and get some of the most unsafe ingredients out of the food supply, which some of the states have now successfully done. Bios Emily Broad Leib is a Clinical Professor of Law, Director of Harvard Law School Center for Health Law and Policy Innovation, and Founding Director of the Harvard Law School Food Law and Policy Clinic, the nation's first law school clinic devoted to providing legal and policy solutions to the health, economic, and environmental challenges facing our food system. Working directly with clients and communities, Broad Leib champions community-led food system change, reduction in food waste, food access and food is medicine interventions, and equity and sustainability in food production. Her scholarly work has been published in the California Law Review, Wisconsin Law Review, Harvard Law & Policy Review, Food & Drug Law Journal, and Journal of Food Law & Policy, among others. Professor Jennifer Pomeranz is a public health lawyer who researches policy and legal options to address the food environment, obesity, products that cause public harm, and social injustice that lead to health disparities. Prior to joining the NYU faculty, Professor Pomeranz was an Assistant Professor at the School of Public Health at Temple University and in the Center for Obesity Research and Education at Temple. She was previously the Director of Legal Initiatives at the Rudd Center for Food Policy and Obesity at Yale University. She has also authored numerous peer-reviewed and law review journal articles and a book, Food Law for Public Health, published by Oxford University Press in 2016. Professor Pomeranz leads the Public Health Policy Research Lab and regularly teaches Public Health Law and Food Policy for Public Health.

Pediatrician and certified life and weight coach Karla Lester discusses her article, "An effective treatment using an effective care delivery model: Using telehealth to treat adolescents with obesity with GLP-1 medications." She shares her frustration with traditional in-person obesity programs that see high attrition and offer few effective treatments beyond surgery. Karla explains how she founded her own practice, Metabolic Telehealth, to implement the latest AAP guidelines by combining a new care delivery model with new medical treatments. The conversation explores her initial data, which shows how telehealth can reduce barriers like weight stigma and travel time, leading to better patient retention. It also highlights the effectiveness of GLP-1 medications, with 95 percent of her long-term patients seeing a BMI reduction. However, she also reveals a critical obstacle: over half of all insurance prior authorizations for these vital medications are denied, forcing many families to pay out of pocket. The core message is that while this telehealth model is effective, systemic change is needed to ensure all adolescents have access to this life-changing care. Careers by KevinMD is your gateway to health care success. We connect you with real-time, exclusive resources like job boards, news updates, and salary insights, all tailored for health care professionals. With expertise in uniting top talent and leading employers across the nation's largest health care hiring network, we're your partner in shaping health care's future. Fulfill your health care journey at KevinMD.com/careers. VISIT SPONSOR → https://kevinmd.com/careers Discovering disability insurance? Pattern understands your concerns. Over 20,000 doctors trust us for straightforward, affordable coverage. We handle everything from quotes to paperwork. Say goodbye to insurance stress – visit Pattern today at KevinMD.com/pattern. VISIT SPONSOR → https://kevinmd.com/pattern SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode, Dr. Rena Malik welcomes Dr. Lora Shahine to explore the essentials of fertility optimization for both men and women. Together, they discuss practical lifestyle changes, the role of supplements, the impact of stress and environmental toxins, and clarify myths around conception, sex, and in vitro fertilization. Listeners will gain actionable insights on preparing for pregnancy, navigating miscarriage, and supporting overall reproductive health with empathy and evidence-based advice. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00:00 Introduction 00:02:55 Male fertility optimization 00:06:45 Diet and fertility 00:09:27 Stress and conception 00:11:41 Obesity and male fertility 00:19:22 Orgasms, sex, conception 00:27:31 Preconception checklist 00:43:00 Frequency and timing sex 00:53:43 IVF process and misconceptions 01:00:34 Miscarriage and support Stay connected with Dr. Lora Shahine on social media for daily insights and updates. Don't miss out—follow her now and check out these links! INSTAGRAM - https://www.instagram.com/drlorashahine/?hl=en TIKTOK - https://www.tiktok.com/@drlorashahine?lang=en YOUTUBE - https://www.youtube.com/c/drlorashahine X - https://x.com/drlorashahine?lang=en WEBSITE - https://drlorashahine.com/ Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning eating patterns with the body's natural circadian rhythms can improve weight, blood pressure, glucose regulation, and other risk factors, especially in individuals with metabolic syndrome or type 2 diabetes. Wilkinson highlights promising results from time-restricted eating studies conducted in collaboration with UC San Diego and the Salk Institute, where narrowing the daily eating window led to improved metabolic markers and potential benefits beyond weight loss. He also outlines practical tips for safely adopting this lifestyle approach and stresses the importance of ongoing research. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40319]

Send us a textWelcome back Rounds Table Listeners! We are back today with a Classic Rapid Fire episode. This week, Drs. Mike and John Fralick discuss two recent papers: the effects of infrequent zoledronate administration on vertebral fracture prevention in early postmenopausal women, and the efficacy and safety of semaglutide in adults with type 1 diabetes and obesity. Two papers, here we go!Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age (0:00 – 10:24)Semaglutide in Adults with Type 1 Diabetes and Obesity (10:25 – 17:48)And for the Good Stuff (17:49 – 19:46):Canadian tennis player Victoria Mboko wins the Canadian Open!The I'm Pharmacy podcast— coming soon to www.medicinepods.com.Thank you to our sponsor, FIGS scrubs. Rounds Table listeners can save 20% on their next purchase with code FIGSCA at https://www.wearfigs.com/.Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

America's Pet Obesity Problem Obesity is troubling about 3 out of every 5 pets. This week, we're tackling this problem with stories, tips, and tricks to keep your pet healthy and happy. You'll hear about the kitty that ate McDonald's every day, an inventor that created a cat-treadmill, and a 77 lb. Dachshund. Listen Now Top Behavioral Problem Separation Anxiety not only tops the list of dog behavior problems, but it's most often brought on by the dog's owner or guardian without knowing it. Alan Kabel has sure-fire ways to teach an old dog new tricks. Listen Now Dogs Going Postal Dogs go postal in Los Angeles more than any other U.S. city. The U.S. Postal Service released its rankings of the best and worst cities for dog attacks on mail carriers. Los Angeles recorded 69 incidents last year. San Antonio and Seattle round out the top three worst cities. Wichita, Kansas, is the safest city with just 20 attacks. Almost six thousand postal workers were attacked by dogs. Listen Now Worm Season With Mosquito season comes an increase in parasitic worms that could ultimately be fatal. Joey Villani tells you how to keep the skeeters away, and Dr. Joel Ehrenzweig tells listeners about over-the-counter products that are safe for your pets, but put a damper in any worm's day. Listen Now Dogs Good For Our Hearts The American Heart Association (AHA) has declared that pets, especially dogs, are good for a person's heart. Further proof that dogs are among the best friends a person could have. Dr. Glenn N. Levine, director of Baylor University's cardiac care unit, says, "Pet ownership, particularly dog ownership, is probably associated with a decreased risk of heart disease." Listen Now Plus, the Animal Radio Dream Team answers questions about your pet. Read more about this week's show.

Dr. Marie-Pierre St-Onge, a nutrition scientist and the founding director of the Center for Excellence for Sleep and Circadian Research at Columbia University, details the intriguing relationship between diet and sleep quality, exploring how various foods and nutrients affect sleep patterns. Dr. St-Onge shares insights from her research on the Mediterranean diet, functional foods, and the impact of macronutrients like fiber, carbohydrates, and polyphenols on sleep. They also touch on the effects of caffeine and alcohol, as well as the role of psychological interventions like Cognitive Behavioral Therapy for insomnia. Practical advice and delicious recipes from her new book, “Eat Better, Sleep Better,” are highlighted to help listeners enhance their sleep through dietary changes.

Dr. Hoffman continues his conversation with Dr. Marie-Pierre St-Onge, a nutrition scientist, the founding director of the Center for Excellence for Sleep and Circadian Research at Columbia University, and author of “Eat Better, Sleep Better.”

What if your struggle with food isn't about willpower—but about unhealed pain?In this raw and powerful episode of Normalize The Conversation, trauma-informed coach and Out of the Cave founder Lisa Schlosberg, LMSW, shares her personal journey from childhood obesity to extreme dieting—and how she finally broke free from diet culture for good.We explore:✅ The toxic truth behind diet culture and emotional eating✅ How restriction and obsession with weight keep us stuck✅ Why lasting healing is about compassion, not control✅ How to build a peaceful relationship with food, body image, and selfThis is not another weight loss story. It's a conversation about freedom.

Liver disease doesn't always show symptoms, but it can have serious consequences. Gastroenterologist Dr. Supriya Joshi explains how excess weight and high blood pressure can silently affect liver health, what people with diabetes should know, what warning signs to watch for and what can actually reverse the damage. #DiabetesPrimetime #LiverHealthThis episode is brought to you by ReliOn Community, an amazing program available exclusively for Walmart customers with a ReliOn Premier meter. Get free diabetes tips, recipes and support sent right to your phone– visit ReliOnBGM.com/community to learn more. The medical information in this podcast is provided as an information resource only. It is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.

Weight bias is a problem that is often overlooked in our society, which is why advocacy is so crucial. We spoke with Lisa Schaffer, the Executive Director of Obesity Canada, about this important issue...The medical information in this podcast is provided as an information resource only. It is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.This episode was sponsored by Novo Nordisk. It was created independently by My Weight - What to Know with no influence from Novo Nordisk.

Support YDS on Patreon!This week, Zoë and Kylee tackle the carnivore diet, the internet's most extreme eating trend. From raw liver smoothies at Erewhon to shirtless influencers promising that “meat heals everything,” the carnivore diet has exploded in popularity. But what really happens when you cut out all plants and live on ribeye steaks, bacon, and bone broth?We explore the strange history of meat-only diets, from 1920s Bellevue experiments to modern influencers like Shawn Baker and Paul Saladino. We unpack the claims about plant “toxins,” the allure of ketosis, and why athletes, especially women, need carbs for performance, recovery, and hormone health. And we dig into the environmental cost of ribeye-heavy eating, why beef is one of the most resource-intensive foods on the planet, and how climate denial often gets wrapped into carnivore culture.So should you go full T-Rex? Probably not. But understanding the hype—and the risks—shows why restrictive food fads keep spreading, and why carbs are still essential for endurance athletes and long-term health.Support the ShowEternal – To check out Foundations, use the promo code YDS for 10% a one year membership.Tailwind Nutrition offers science–backed endurance fuel that actually works. Try our favorite, Blueberry Lemonade Endurance Fuel - Get 20% off your first order with code YOURDIET20Janji – Adventure-ready running gear with pockets that actually work. Use code YDS for 10% off your order.Microcosm Coaching – Human-first, athlete-centered coaching for every runner, from 5K to 100 miles and beyond.REFERENCESBurke, L. M., Ross, M. L., Garvican-Lewis, L. A., Welvaert, M., Heikura, I. A., Forbes, S. G., ... & Hawley, J. A. (2017). Low carbohydrate, high fat diet impairs exercise economy and negates the performance benefit from intensified training in elite race walkers. The Journal of Physiology, 595(9), 2785–2807. https://doi.org/10.1113/JP273230Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., ... & Brand-Miller, J. (2005). Origins and evolution of the Western diet: Health implications for the 21st century. The American Journal of Clinical Nutrition, 81(2), 341–354. https://doi.org/10.1093/ajcn.81.2.341Hall, K. D., & Guo, J. (2017). Obesity energetics: Body weight regulation and the effects of diet composition. Gastroenterology, 152(7), 1718–1727. https://doi.org/10.1053/j.gastro.2017.01.052Jönsson, T., Granfeldt, Y., Lindeberg, S., & Hallberg, A. C. (2009). Subjective satiety and other experiences of a Paleolithic diet compared to a diabetes diet in patients with type 2 diabetes. Nutrition Journal, 8(1), 35. https://doi.org/10.1186/1475-2891-8-35Lerner, R. (1930). Adventures in diet. Harper's Monthly Magazine, 161(962), 509–518.Micha, R., Michas, G., & Mozaffarian, D. (2012). Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes: An updated review of the evidence. Current Atherosclerosis Reports, 14(6), 515–524. https://doi.org/10.1007/s11883-012-0282-8O'Hearn, A., Tro, K., & Naiman, D. (2021). Clinical experience of medical doctors with a carnivore diet. Current Developments in Nutrition, 5(Supplement_2), 393. https://doi.org/10.1093/cdn/nzab044_067Stefansson, V. (1946). Not by bread alone. New York, NY: Macmillan.UN Food and Agriculture Organization. (2013). Tackling climate change through livestock: A global assessment of emissions and mitigation opportunities. Rome: FAO.Zhang, Y., Pan, X. F., Chen, J., Xia, L., Cao, A., Zhang, Y., ... & Pan, A. (2021). Associations of red meat, processed meat, and poultry consumption with risk of colorectal cancer: A prospective cohort study of 0.5 million Chinese adults. International Journal of Cancer, 149(5), 979–989. https://doi.org/10.1002/ijc.33694

CEO and Founder of KetoNatural Pet Foods, Daniel Schulof, returns to explain the new Pet Food Nutrition Facts labeling system and what it means for pet owners. We also get an update on his company's lawsuit that, if successful, will have a transformative impact on the pet food industry. Even if you are not a pet owner, Dan's visits are always lively, engaging, and informative. His story offers insight into the challenges that startups can face against the big players in any industry.The KetoNatural fundraising campaigThe new Pet Nutrition Facts labelKetoNatural online:KetoNaturalPetFoods.comInstagram.com/ketonaturalpetfoodsFacebook.com/ketonaturalpetfoodsYouTube.com/channel/UC3zjG_ADUs14xBIJZcUZ8Lw/videosTikTok.com/@ketonaturalpetfoodsListen to Daniel's previous visits to Dog Words:0507: Big Dog Food with Daniel Schulof0419: Canine Nutrition with Daniel SchulofSupport Rosie Fund by booking a session with BigfootPetPhotography.com.Music for this episode is provided by alternative string duo, The Wires. Visit them at TheWires.info. Learn fiddle and cello-fiddle online — even if you've never played before — from Laurel Morgan Parks and Sascha Groshang at FiddleLife.com.Make a donation at RosieFund.org or through our Facebook page. You can contribute by making a purchase from the store on our website or buying a t-shirt at Bonfire.com. Also check out our page on BarkYours, the online mall with gifts for people who love their dogs.Rosie Fund online:RosieFund.orgFacebook.com/rosiefundInstagram.com/rosiefundYouTube.com/rosiefund

Dr. Robert Silverman, author of "Immune Reboot: Maximizing Immunity, Restoring Gut Health, and Optimizing Vitality," provides a comprehensive primer on the immune system. He explains how lifestyle factors—diet, sleep, exercise, and stress—impact immune resilience. He offers specific protocols for optimizing resistance to Covid, what to do if you come down with it, and how to treat Long Covid, as well as how to prepare for vaccines. 

Dr. Hoffman continues his conversation with Dr. Robert Silverman, author of "Immune Reboot: Maximizing Immunity, Restoring Gut Health, and Optimizing Vitality."

https://linktr.ee/manonthemounjaro

In this episode of For Pet's Sake, Mark Scott sits down with Dr. Conor Brady to tackle the growing issue of pet obesity. Studies show that 59% of dogs and 61% of cats are overweight or obese, yet many owners don't realise the serious health risks associated with excess weight. Dr. Brady explains that obesity in pets leads to chronic inflammation, joint problems, reduced lifespan, and increased veterinary costs.They discuss why the pet health sector has struggled to address obesity effectively, highlighting that unlike human healthcare systems, there is little financial incentive for companies to reduce obesity rates in pets. They also critique the common veterinary approach of recommending high-carbohydrate diets like kibble, despite research showing that increasing protein and reducing carbohydrates supports safe and sustainable weight loss.Dr. Brady emphasises the benefits of feeding pets whole, natural foods that are easier to digest than ultra-processed, chemically preserved options. Raw feeding is discussed as a closer-to-nature approach that naturally reduces carbohydrate intake and helps maintain a healthy weight. Practical tips for owners include aiming for a lean body condition where ribs can be felt but not necessarily seen, incorporating hydrotherapy or acupuncture for older or recovering dogs, and avoiding high-fibre “light” kibbles—particularly for brachycephalic breeds—due to links with panting and bloat.This episode is essential listening for pet owners looking to support healthy weight management, improve their pet's overall wellbeing, and prevent obesity-related illnesses. Learn actionable strategies to help your dog or cat achieve a happy, healthy, and active lifestyle.

Sometimes the most tempting quick fixes, like eating only one type of food, can actually set you back on your health journey. In this episode, I explored the viral TikTok trend known as the watermelon diet, breaking down why it may seem tempting but is ultimately risky and unsustainable. I shared a story about a friend who was pressured to try it and explained how social media can create unrealistic expectations and comparisons. While watermelon has health benefits like hydration, low calories, and vitamins, I highlighted the dangers of relying on it exclusively—nutrient deficiencies, loss of muscle mass, blood sugar spikes, digestive issues, and unsustainable weight loss. I emphasized that real progress comes from balance: eating a variety of nutrient-rich foods, staying consistent with healthy habits, moving in enjoyable ways, managing stress, and prioritizing rest. Most importantly, I reminded listeners to focus on their own journey, celebrate small wins, and not let social media dictate their worth.   Tune in to discover the truth behind viral diet trends and learn healthier, lasting ways to reach your goals.   Episode Highlights: The rise of the viral watermelon diet on social media Why extreme mono fruit diets are risky and unsustainable Health benefits of watermelon in moderation Nutrient deficiencies and health risks linked to the diet The role of comparison and pressure from social media Science-backed strategies for balanced, long-term weight loss Importance of mindset, consistency, and celebrating small wins Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Report shows rapid declines in health of children and adolescents since 2007; N-acetylcysteine (NAC) for Parkinson's; Statins increase likelihood of hearing loss, tinnitus; Lithium orotate for Alzheimer's; Is tinnitus reversible? Novel implantable electrical vagus nerve stimulator approved for treatment of rheumatoid arthritis.

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Have you ever been told that your weight is just a matter of willpower?Or that if you simply “tried harder,” you'd get the results you want? Maybe you've even heard that using medication or surgery is “cheating.” If so, you're far from alone, and it's time to call BS on that idea.If you've ever felt shame or guilt about your weight, know this: it's not your fault. Obesity is a complex, chronic disease shaped by biology, hormones, genetics, and environment, not a personal weakness. While healthy eating and exercise are always important, they are often not enough on their own. That's where medical tools like medications and surgery come in, not as shortcuts but as treatments grounded in evidence.Over the past few weeks, I've had experiences that reminded me why this conversation is still so important. Some were inspiring, like connecting with state leaders working to expand access to obesity care. Others were frustrating: clear signs that weight bias still exists in medicine and media alike.In this episode, I will share three stories that show how weight bias appears in everyday life and why challenging it matters. These examples might make you shake your head, but I hope they also give you the words to push back and remind yourself that your health deserves recognition at every step forward.Catch the full episode to hear all three stories and get practical ways to challenge weight bias in your own life.Article: Questioning the Cause of ObesityPodcast Episode: What Are Obesogens with Dr. YoungloveConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss treatment of OSA. In Part 1 we discussed and overview of OSA, in Part 2 we discussed making the diagnosis will, and Part 4 will look at cases. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Sanjay Patel, M.D, Professor of Medicine, Epidemiology, & Clinical and Translational Science, and Director of the Center for Sleep and Cardiovascular Outcomes Research; Medical Director of the Comprehensive Sleep Disorders Program, University of Pittsburgh Medical Center Selected references: Diagnosis and Management of Obstructive Sleep Apnea - A Review. JAMA. 2020;323(14):1389-1400 Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 2024;391:1193-1205

Send us a message with this link, we would love to hear from you. Standard message rates may apply.Metabolic adaptation is a powerful physiological process that explains why weight loss is so challenging and why keeping it off can feel like your body is working against you.• Your body burns fewer calories than expected after weight loss, creating an "energy gap"• For every kilogram lost, metabolism slows by approximately 25 calories• Weight loss affects hormones like leptin (satiety) and ghrelin (hunger) that control appetite• Metabolic adaptation is a survival mechanism, not a personal failure or lack of willpower• Research suggests metabolic adaptation is strongest during weight loss and the first few months after• Evidence from "The Biggest Loser" contestants suggests extreme weight loss may cause longer-lasting metabolic changes• Exercise (200-300 minutes weekly) helps counteract metabolic adaptation• High-protein, high-fiber diets with low glycemic loads help manage increased hunger• Even modest weight loss (5-10%) significantly improves health markers like blood pressure and blood sugar• Medical interventions like GLP-1 medications and bariatric surgery can help address the hormonal drivers of weight regainCheck out our website and find us on threads. You can email us at yourcheckuppod@gmail.com or send us fan mail. We'd love to hear from you!Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

***JOIN THE NEXT MASTER YOUR FASTING CHALLENGE THAT STARTS August 13th, 2025!*** We'll GUIDE you on how to FAST to LOSE FAT for good, and use ‘fast cycling' to achieve uncommon results! REGISTER HERE! Click the link for DATES, DETAILS, and FAQs! This episode addresses the alarming metabolic health crisis affecting American families, with shocking CDC data revealing that 1 in 3 adolescents (33%) now meet prediabetes criteria - up 5% in just two years. Dr. Scott and Tommy explore how 74% of Americans are overweight or obese, with severe obesity tripling since 2008, and discuss why traditional BMI measurements miss the crucial factor of visceral fat and insulin resistance. Learn why metabolic health matters more than the number on the scale, with practical strategies for measuring waist-to-height ratio and understanding body composition versus simple weight tracking. The hosts share real-world parenting approaches for creating healthy family food environments without restricting children's growth, including their "8-to-8 kitchen hours" rule, teaching kids to distinguish between hunger and boredom, and explaining food as fuel rather than creating "good food/bad food" shame cycles. Discover how intermittent fasting principles can naturally integrate into family routines through consistent meal timing, post-dinner kitchen closure, and modeling healthy relationships with food. This episode provides actionable strategies for breaking generational health patterns, including how to discuss nutrition with children using car/superhero analogies, involving kids in meal planning, and creating positive food conversations that emphasize what to include rather than restrict. Essential listening for parents, grandparents, and anyone wanting to influence their family's long-term metabolic health while understanding the deeper health markers that truly matter beyond scale weight. ⁠Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting!⁠⁠⁠⁠⁠ Resources and Downloads: ⁠⁠⁠⁠⁠SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! ⁠⁠⁠ ⁠⁠⁠⁠⁠FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS!⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠SLEEP GUIDE DIRECT DOWNLOAD⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE!⁠⁠⁠⁠⁠ Partner Links: Get your⁠⁠⁠⁠⁠ FREE BOX OF LMNT⁠⁠⁠⁠⁠ hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase⁠⁠⁠⁠⁠ here!⁠⁠⁠⁠⁠ Get ⁠⁠⁠⁠⁠25% off a Keto-Mojo⁠⁠⁠⁠⁠ blood glucose and ketone monitor (discount shown at checkout)! ⁠⁠⁠⁠⁠Click here!⁠⁠⁠⁠⁠ Our Community: Let's continue the conversation. Click the link below to JOIN the ⁠⁠⁠⁠⁠Fasting For Life Community⁠⁠⁠⁠⁠, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them! Article Links: https://www.levels.com/blog/what-can-weight-tell-you-about-your-metabolic-health?__s=72dghf497nkahcwgdg5y https://www.cdc.gov/nchs/nhanes/index.html